Dec 20 (Reuters) - Anatara Lifesciences Ltd (ANR) :
- UPDATES ON PROTOCOL FOR ITS CLINICAL TRIAL IN IRRITABLE BOWEL SYNDROME (IBS) FOR ITS GARP DIETARY SUPPLEMENT.
- MET PROJECTED MILESTONE TO FINALISE DRAFT PROTOCOL FOR HUMAN CLINICAL TRIAL FOR GASTROINTESTINAL REPROGRAMMING DIETARY SUPPLEMENT
Dec 20 (Reuters) - Anatara Lifesciences Ltd (ANR) : UPDATES ON...
Add to My Watchlist
What is My Watchlist?